Navigation Links
Prostate Cancer Radiotherapy Won't Affect Sexual Function
Date:10/29/2007

New high-dose technology targets tumor tissue, experts say

MONDAY, Oct. 29 (HealthDay News) High-dose precision radiation therapy doesn't harm the sexual function of prostate cancer patients, U.S. researchers say.

A team at Fox Chase Cancer Center in Philadelphia tracked 155 men with intermediate- to high-risk prostate cancer who underwent intensity-modulated radiation therapy (IMRT), a technique that more precisely targets the tumor.

"IMRT is revolutionizing how we treat men with prostate cancer, because it improves our ability to avoid normal tissue. As a result, more radiation dose can be delivered to the prostate by increasing the amount of radiation each day. Increasing the radiation used each day is particularly attractive, because it also shortens the treatment time by several days," study lead author Dr. Mark Buyyounouski, attending physician in the radiology department at Fox Chase, said in a prepared statement.

"We need to make sure there's a balance between risk and benefit, and sexual function is a major consideration. Fortunately, this study shows no decrease in sexual function from the higher doses of radiation," he said.

One group of men in the study received 2 Gy of radiation in 38 sessions over seven weeks, three days, while another group received 2.7 Gy in 26 sessions over five weeks, one day. At six months, one year, and two years after treatment, there were no significant differences in sexual function scores between the two groups.

The findings were expected to be presented Monday at the annual meeting of the American Society for Therapeutic Radiology and Oncology, in Los Angeles.

More information

The American Academy of Family Physicians outlines prostate cancer treatments.



-- Robert Preidt



SOURCE: Fox Chase Cancer Center, news release, Oct. 29, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. More Accurate "PROSTATE CANCER" Test can save Unnecessary Biopsies
3. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
4. Better prostate cancer detection
5. Protective effects of tomatoes in prostate cancer
6. Early detection of prostate cancer
7. Prevention of Prostate Cancer
8. Low grade prostate cancer may be treated with mild treatment
9. British MPs Say Prostate Cancer Receives Low Priority in the NHS
10. Diagnosing Prostate Cancer is Harder in Obese Individuals
11. Fingerprinting prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... ... The Bank of America Charitable Foundation has awarded a grant to the General ... employment and successful careers in healthcare. On Wednesday, May 4th, Rick Bridwell, Bank of ... Medisend, parent organization and home of the General Myers Veterans Program. , “The ...
(Date:5/25/2016)... ... ... CloudLIMS, joins an elite number of companies that have earned a spot ... by CIOReview. , In a deliberate session with the honorary industrial experts, a list ... concluded with. The positioning is based on evaluation of CloudLIMS’ specialties in Automated Sample ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Global Wellness Summit ... unique integrative medical wellness offerings of Europe, a continent that pioneered the medical/wellness concept ... hear from numerous pioneers in medical wellness, including Henri Chenot, Founder of the Chenot ...
(Date:5/25/2016)... FRANCISCO, CA (PRWEB) , ... May 25, 2016 , ... ... School of Nursing and Health Professions. She will lead a team of more than ... Team. Baker will begin her role as dean in late August. , Baker comes ...
(Date:5/25/2016)... ... May 25, 2016 , ... BeniComp Insurance Company, a ... in their clients' employee participation for their wellness initiatives. BeniComp clients experience ... high-deductible health plan with outcome-based deductible incentives. As a result, BeniComp clients have ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient dringenden ... Brustkrebs   QIAGEN N.V. (NASDAQ: ... heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit Therawis ... für die Onkologie eingegangen zu sein. Ein erstes ...
(Date:5/25/2016)... 25, 2016 According to market ... Growth and Demand Forecast to 2022 - Industry Insights ... Others)" published by P&S Market Research, the global insulin ... 2015, and it is expected to grow at a ... insulin pump segment is expected to witness the fastest ...
(Date:5/25/2016)... MedDay, a biotechnology company focused on ... presentation entitled "High doses of biotin in progressive multiple sclerosis: ... by Professor Ayman Tourbah , Principal Investigator of the ... Academy of Neurology (EAN) in Copenhagen, Denmark ... take place on Sunday, 29 May 2016 from 14:45 to ...
Breaking Medicine Technology: